>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Perkins Capital Management Inc Buys Interpace Biosciences Inc, CareDx Inc, Gilead Sciences Inc, Sells Interpace Biosciences Inc, Aflac Inc, Microvision Inc

Wayzata, MN, based Investment company Perkins Capital Management Inc (Current Portfolio) buys Interpace Biosciences Inc, CareDx Inc, Gilead Sciences Inc, BioTelemetry Inc, Rockwell Medical Inc, sells Interpace Biosciences Inc, Aflac Inc, Microvision Inc, The Joint Corp, Chembio Diagnostics Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Perkins Capital Management Inc. As of 2020Q1, Perkins Capital Management Inc owns 103 stocks with a total value of $80 million. These are the details of the buys and sells.

For the details of PERKINS CAPITAL MANAGEMENT INC's stock buys and sells, go to https://www.gurufocus.com/guru/perkins+capital+management+inc/current-portfolio/portfolio

These are the top 5 holdings of PERKINS CAPITAL MANAGEMENT INC
  1. NeoGenomics Inc (NEO) - 234,850 shares, 8.07% of the total portfolio. Shares reduced by 6.99%
  2. Vericel Corp (VCEL) - 344,397 shares, 3.93% of the total portfolio. Shares reduced by 2.59%
  3. Axogen Inc (AXGN) - 298,240 shares, 3.86% of the total portfolio. Shares added by 0.49%
  4. Veracyte Inc (VCYT) - 121,730 shares, 3.68% of the total portfolio. Shares reduced by 8.22%
  5. IDEXX Laboratories Inc (IDXX) - 11,205 shares, 3.38% of the total portfolio. Shares reduced by 1.28%
New Purchase: Interpace Biosciences Inc (PF42)

Perkins Capital Management Inc initiated holding in Interpace Biosciences Inc. The purchase prices were between $0.58 and $9.8, with an estimated average price of $6.33. The stock is now traded at around $4.76. The impact to a portfolio due to this purchase was 1.45%. The holding were 224,107 shares as of .

New Purchase: Gilead Sciences Inc (GILD)

Perkins Capital Management Inc initiated holding in Gilead Sciences Inc. The purchase prices were between $62.63 and $80.22, with an estimated average price of $68.92. The stock is now traded at around $83.98. The impact to a portfolio due to this purchase was 0.99%. The holding were 10,600 shares as of .

New Purchase: Itamar Medical Ltd (ITMR)

Perkins Capital Management Inc initiated holding in Itamar Medical Ltd. The purchase prices were between $7.95 and $17.54, with an estimated average price of $13.69. The stock is now traded at around $14.61. The impact to a portfolio due to this purchase was 0.29%. The holding were 20,000 shares as of .

New Purchase: SenesTech Inc (SE8)

Perkins Capital Management Inc initiated holding in SenesTech Inc. The purchase prices were between $1.38 and $10.5, with an estimated average price of $5.32. The stock is now traded at around $2.14. The impact to a portfolio due to this purchase was 0.21%. The holding were 81,875 shares as of .

New Purchase: Digi International Inc (DGII)

Perkins Capital Management Inc initiated holding in Digi International Inc. The purchase prices were between $6.4 and $17.72, with an estimated average price of $13.97. The stock is now traded at around $12.08. The impact to a portfolio due to this purchase was 0.13%. The holding were 10,800 shares as of .

New Purchase: TransEnterix Inc (TRXC)

Perkins Capital Management Inc initiated holding in TransEnterix Inc. The purchase prices were between $0.29 and $1.64, with an estimated average price of $1.06. The stock is now traded at around $0.44. The impact to a portfolio due to this purchase was 0.1%. The holding were 224,117 shares as of .

Added: CareDx Inc (CDNA)

Perkins Capital Management Inc added to a holding in CareDx Inc by 51.15%. The purchase prices were between $13.94 and $28.25, with an estimated average price of $22.48. The stock is now traded at around $26.96. The impact to a portfolio due to this purchase was 1.13%. The holding were 122,633 shares as of .

Added: BioTelemetry Inc (BEAT)

Perkins Capital Management Inc added to a holding in BioTelemetry Inc by 65.18%. The purchase prices were between $28.93 and $55.27, with an estimated average price of $46.28. The stock is now traded at around $48.26. The impact to a portfolio due to this purchase was 0.73%. The holding were 38,735 shares as of .

Added: Rockwell Medical Inc (RMTI)

Perkins Capital Management Inc added to a holding in Rockwell Medical Inc by 29.93%. The purchase prices were between $1.56 and $3.57, with an estimated average price of $2.59. The stock is now traded at around $2.42. The impact to a portfolio due to this purchase was 0.57%. The holding were 965,900 shares as of .

Added: Vonage Holdings Corp (VG)

Perkins Capital Management Inc added to a holding in Vonage Holdings Corp by 63.26%. The purchase prices were between $4.53 and $10.7, with an estimated average price of $8.16. The stock is now traded at around $8.44. The impact to a portfolio due to this purchase was 0.54%. The holding were 155,550 shares as of .

Added: Alphatec Holdings Inc (ATEC)

Perkins Capital Management Inc added to a holding in Alphatec Holdings Inc by 117.15%. The purchase prices were between $2.26 and $7.47, with an estimated average price of $5.81. The stock is now traded at around $4.88. The impact to a portfolio due to this purchase was 0.43%. The holding were 186,750 shares as of .

Added: Profire Energy Inc (PFIE)

Perkins Capital Management Inc added to a holding in Profire Energy Inc by 70.70%. The purchase prices were between $0.7 and $1.5, with an estimated average price of $1.23. The stock is now traded at around $0.78. The impact to a portfolio due to this purchase was 0.43%. The holding were 1,049,489 shares as of .

Sold Out: Interpace Biosciences Inc (IDXG)

Perkins Capital Management Inc sold out a holding in Interpace Biosciences Inc. The sale prices were between $4.9 and $10.55, with an estimated average price of $7.25.

Sold Out: Aflac Inc (AFL)

Perkins Capital Management Inc sold out a holding in Aflac Inc. The sale prices were between $25.27 and $53.42, with an estimated average price of $46.04.

Sold Out: Microvision Inc (MVIS)

Perkins Capital Management Inc sold out a holding in Microvision Inc. The sale prices were between $0.17 and $0.77, with an estimated average price of $0.51.

Sold Out: The Joint Corp (JYNT)

Perkins Capital Management Inc sold out a holding in The Joint Corp. The sale prices were between $8.14 and $17.3, with an estimated average price of $14.74.

Sold Out: Chembio Diagnostics Inc (CEMI)

Perkins Capital Management Inc sold out a holding in Chembio Diagnostics Inc. The sale prices were between $2.36 and $5.6, with an estimated average price of $4.05.

Sold Out: ANI Pharmaceuticals Inc (ANIP)

Perkins Capital Management Inc sold out a holding in ANI Pharmaceuticals Inc. The sale prices were between $30.35 and $67.14, with an estimated average price of $53.63.



Here is the complete portfolio of PERKINS CAPITAL MANAGEMENT INC. Also check out:

1. PERKINS CAPITAL MANAGEMENT INC's Undervalued Stocks
2. PERKINS CAPITAL MANAGEMENT INC's Top Growth Companies, and
3. PERKINS CAPITAL MANAGEMENT INC's High Yield stocks
4. Stocks that PERKINS CAPITAL MANAGEMENT INC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)